Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | HNF4A | P41235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24490482 | 0.90 | PDK2 (0.36) | — | |
| SCHEMBL21431242 | 0.90 | HSD17B3 (0.31) | MAPTHSD17B3 | |
| SCHEMBL18012797 | 0.89 | KMT2A (0.36) | KMT2AL3MBTL1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL18012814 | 0.88 | MAPT (0.38) | KMT2AL3MBTL1POLBMAPTSMN1; SMN2 | |
| SCHEMBL18012762 | 0.87 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL18012806 | 0.86 | RAB9A (0.38) | KMT2AL3MBTL1POLBALDH1A1 | |
| SCHEMBL21431115 | 0.84 | PDK2 (0.30) | — | |
| SCHEMBL21431118 | 0.84 | PDK2 (0.32) | — | |
| SCHEMBL18012730 | 0.83 | MAPT (0.35) | KMT2AL3MBTL1POLBMAPTSMN1; SMN2 | |
| SCHEMBL18235854 | 0.83 | PDK2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016126070-A1 | NOVEL OXIMESTER DERIVATIVE COMPOUND, AND PHOTOPOLYMERIZATION INITIATOR AND PHOTORESIST COMPOSITION CONTAINING SAME | 한국화학연구원 | 2016-08-11 | — | — | WO | disclosed |